Patient Access

Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.  

Medweb's director of federal business Steven Osborne discusses the company's global teleradiology networks that operate out of remote locations with poor communications infrastructure.

Immersive virtual reality can help create simulated scenes that mirror the real world and simplify it, says Floreo CEO Vijay Ravindran. That is why VR is beneficial for teaching neurodiverse individuals life skills.

Zsolt Kulcsar, Lee Health's systems medical director of virtual health, discusses his team's upcoming AI chatbot, which will contact patients with unusual RPM biometric readings to determine if alerting a nurse is necessary.  

Digital therapeutics can improve health equity by empowering patients to adhere to medication intake, says Tanisha Hill, founder and president of the Digital Health for Equitable Health Alliance. Still, the digital divide needs to be addressed.  

Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.  

Dr. Jeffrey Chen, clinical advisor at No Barrier AI, believes the company's AI medical interpreter app could improve outcomes for low-English-proficiency patients, prevent clinician burnout and reduce operational costs.  

Eric Robertson, chief technology strategist and growth officer at Jeeva Care, talks about how the company's AI companion helps patients track health goals and stick to their care program after a hospital stay.  

Patient advocate Dave deBronkart believes interoperability advances could soon enable everyone to carry International Patient Summary QR codes with their own health data that could be scanned into EHRs in case of emergency.  

Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.